Compare ASTI & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTI | CPHI |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 32.3M |
| IPO Year | 2014 | 2008 |
| Metric | ASTI | CPHI |
|---|---|---|
| Price | $2.36 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 257.7K | 209.9K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,398,149.00 | $4,144,268.00 |
| Revenue This Year | $987.62 | N/A |
| Revenue Next Year | $2,579.52 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 163.25 | N/A |
| 52 Week Low | $1.40 | $0.38 |
| 52 Week High | $9.87 | $19.19 |
| Indicator | ASTI | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 33.16 | 40.28 |
| Support Level | N/A | $0.53 |
| Resistance Level | $3.22 | $0.68 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 1.34 | 14.55 |
Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.